drugset / Trial / NCT03149393
Clinical Study on Post Evaluation After Listing of Qizhi Weitong Granules
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a randomized, double blind, double dummy, multicenter, parallel controlled clinical trial, the investigators objective is to evaluate the efficacy and safety of Qizhi Weitong granules in the treatment of functional dyspepsia.
Timeline
- Start
- 2017-02-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mosapride | Small molecule | 5 mg | — |
| Subject | Qizhi Weitong Granules | Unknown | 2.5 g | — |